All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo

[1]  Peng Li,et al.  Role of urokinase plasminogen activator and its receptor in metastasis and invasion of neuroblastoma. , 2004, Journal of pediatric surgery.

[2]  A. Bahnassy,et al.  Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients , 2004, BMC gastroenterology.

[3]  Tae-You Kim,et al.  AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity , 2004, Oncogene.

[4]  H. Jin,et al.  Integrins: roles in cancer development and as treatment targets , 2004, British Journal of Cancer.

[5]  F. Verrecchia,et al.  Retinoic acid receptors interfere with the TGF-β/Smad signaling pathway in a ligand-specific manner , 2003, Oncogene.

[6]  E. Dmitrovsky,et al.  Retinoids in cancer therapy and chemoprevention: promise meets resistance , 2003, Oncogene.

[7]  S. Jao,et al.  RARRES3 expression positively correlated to tumour differentiation in tissues of colorectal adenocarcinoma , 2003, British Journal of Cancer.

[8]  S. Thorgeirsson,et al.  DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity , 2003, Oncogene.

[9]  S. Hopkinson,et al.  Complex interactions between the laminin α4 subunit and integrins regulate endothelial cell behavior in vitro and angiogenesis in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Timpl,et al.  Binding of mouse nidogen-2 to basement membrane components and cells and its expression in embryonic and adult tissues suggest complementary functions of the two nidogens. , 2002, Experimental cell research.

[11]  P. Nelson,et al.  Evidence That the Human Gene for Prostate Short-chain Dehydrogenase/Reductase (PSDR1) Encodes a Novel Retinal Reductase (RalR1)* , 2002, The Journal of Biological Chemistry.

[12]  J. Renauld,et al.  Proapoptotic activity of ITM2Bs, a BH3-only protein induced upon IL-2-deprivation which interacts with Bcl-2 , 2002, Oncogene.

[13]  R. H. Gross,et al.  Developmentally-related candidate retinoic acid target genes regulated early during neuronal differentiation of human embryonal carcinoma , 2002, Oncogene.

[14]  L. Sanz,et al.  The class II tumor-suppressor gene RARRES3 is expressed in B cell lymphocytic leukemias and down-regulated with disease progression , 2001, Leukemia.

[15]  C. Mantzoros,et al.  Insulin-Like Growth Factor Binding Protein-3 Predicts Survival from Acute Childhood Leukemia , 2001, Oncology.

[16]  M. Haber,et al.  Favorable prognostic significance of high-level retinoic acid receptor β expression in neuroblastoma mediated by effects on cell cycle regulation , 1998, Oncogene.

[17]  A. Winterpacht,et al.  Novel WT1 mutation, 11p LOH, and t(7;12) (p22;q22) chromosomal translocation identified in a Wilms Tumor Case , 1998, Genes, chromosomes & cancer.

[18]  P. Adamson,et al.  Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  R. Ross,et al.  TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. , 1990, Cell.